Christopher Fenimore Will Succeed Robert Landry in the role of CFO at Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), the leading biotechnology company, has officially announced that Robert E. Landry, who currently holds the position of Executive Vice President, Finance and Chief Financial Officer of Regeneron, will retire in February 2024. Following Mr. Landry's retirement, Christopher Fenimore, the current Senior Vice President and Head...